Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model
- 3 June 2022
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 363, 110008
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China National Outstanding Youth Science Fund Project (82004175)
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province (2020YJ0389)
This publication has 50 references indexed in Scilit:
- Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancerAnti-Cancer Drugs, 2014
- Comparison of Cardiac Troponin I and T, Including the Evaluation of an Ultrasensitive Assay, as Indicators of Doxorubicin-induced CardiotoxicityToxicologic Pathology, 2013
- Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse modelToxicology and Applied Pharmacology, 2013
- Troponin leak in heart failure: Moving forward to arrest cardiomyocyte attrition and promote myocardial regenerationInternational Journal of Cardiology, 2013
- Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathwaysCardiovascular Research, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assaysEuropean Heart Journal, 2011
- Adriamycin-induced myocardial toxicity: New solutions for an old problem?International Journal of Cardiology, 2007
- Molecular Pharmacology of the Interaction of Anthracyclines with IronMolecular Pharmacology, 2005
- Congestive heart failure in patients treated with doxorubicinCancer, 2003